| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5887481 | Seminars in Arthritis and Rheumatism | 2016 | 10 Pages |
Abstract
Our study demonstrates that patients with PsA who experience inadequate response or intolerance of traditional DMARDs or NSAIDs have a higher probability of achieving the ACR20 response with older TNF inhibitors and secukinumab.
Related Topics
Health Sciences
Medicine and Dentistry
Anesthesiology and Pain Medicine
Authors
Patompong MD, Charat MD, John M. MD, MS,